| Financial Year |
March 31 2023 |
| Monetary Funds |
564,585,207.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
657,454,669.16 |
| Advances to Suppliers |
329,331,534.11 |
| Other Receivables |
577,214,167.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,494,337,379.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
268,001,252.24 |
| Total Current Assets |
4,102,036,326.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
273,291,782.56 |
| Investment Properties |
280,892,348.80 |
| Fixed Assetes |
2,561,937,066.12 |
| Under-construction Projects |
327,188,735.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
464,194,480.42 |
| R&D expenses |
-- |
| Goodwill |
81,273,451.58 |
| Long-Term Deferred and Prepaid Expenses |
7,019,563.56 |
| Deferred Income Tax Assets |
27,242,972.36 |
| Other Non-Current Assets |
4,452,419.97 |
| Sub-Total of Non-Current Assets |
4,077,425,784.07 |
| Total Assets |
8,179,462,110.94 |
| Short-Term Loans |
1,333,025,794.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
487,557,011.00 |
| Accounts Payable |
545,205,229.14 |
| Accounts Received In Advance |
2,000,418.04 |
| Employee Compensation Payable |
14,153,454.51 |
| Taxes Payable |
24,438,298.60 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
243,387,881.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
270,232,938.98 |
| Other Current Liabilities |
13,680,300.29 |
| Sub-Total of Current Liabilities |
3,110,519,798.42 |
| Long-term Loans |
1,143,954,916.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
31,235,943.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,305,970,071.84 |
| Total Liabilities |
4,416,489,870.26 |
| Paid-In Capital(Or Share Stock) |
470,401,000.00 |
| Capital Surplus |
1,439,497,814.10 |
| Surplus Reserve |
147,069,557.17 |
| LESS:Treasury Stock |
149,509,678.65 |
| Undistributed Profits |
1,761,982,550.75 |
| Minority Stockholder's Interest |
120,575,789.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,642,396,451.57 |
| Owner's Equity（Stockholder's Equity） |
3,762,972,240.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,179,462,110.94 |
